Skip to main content
Figure 5 | BMC Biotechnology

Figure 5

From: Recombinant gas vesicles from Halobacterium sp. displaying SIV peptides demonstrate biotechnology potential as a pathogen peptide delivery vehicle

Figure 5

Verification of recombinant GvpC protein formation and incorporation into functional gas vesicles. Western blots were used to assess putative recombinant gas vesicles (Panel A) and cell lysates (Panel B) for the presence of r-GvpC protein. Here samples are resolved in 8–16% SDS-PAGE gels, immunoblotted and probed with rabbit anti-GvpC antibody. The size range of the protein standards (kDa) is indicated at the left and the recombinant GvpC protein bands are identified at the right.

Back to article page

BMC Biotechnology

ISSN: 1472-6750

Contact us